SOMMER LLOYD: Open Payments
NPI 1700476272 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 11 payments from 10 companies in 2025. Trend: 2023 $962 · 2024 $890 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ABBVIE INC. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Insulet Corporation | 1 | $23 |
| CeQur Corporation | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: CRENESSITY, SYNTHROID, LEQVIO, Omnipod, CeQur Simplicity, Korlym, JARDIANCE, UNITHROID.
Industry payments across MD — which companies pay providers there.
